[CH2:1]([S:5]([NH2:8])(=[O:7])=[O:6])[CH2:2][CH2:3][CH3:4].[H-].[Na+].CS(OCC1CCN([O:23][CH2:24][C:25]2[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=2)C(=C=O)C1)(=O)=O.O.[CH3:34][N:35]([CH:37]=[O:38])[CH3:36]>ClC(Cl)(Cl)Cl>[CH2:1]([S:5]([NH:8][CH2:24][CH:25]1[CH2:30][CH2:36][N:35]([C:37]([O:23][CH2:24][C:25]2[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=2)=[O:38])[CH2:34][CH2:26]1)(=[O:7])=[O:6])[CH2:2][CH2:3][CH3:4]A solution of n-butylsulphonamide (500 mg) in DMF (5 ml) was added dropwise to a suspension of sodium hydride (150 mg, 60% dispersion in mineral oil) in DMF (10 ml) and the mixture was stirred for 10 minutes. 4-Methanesulphonyloxymethyl-N-benzyloxy-carbonylpiperidine (1.09 g) was added and the mixture heated at 80° C. for 16 hours. The mixture was cooled, poured into water (100 ml) and extracted with ethyl acetate (3×50 ml). The combined organic extracts were washed with water (3×50 ml) and saturated aqueous sodium chloride (50 ml), dried (MgSO4) and concentrated. The residual oil was purified by flash column chromatography, eluting with methanol/dichloromethane (1:99) to give a colourless semi-solid. This mixture was dissolved in warm tetrachloromethane (6 ml) and cooled to give 4-n-butylsulphonylaminomethyl-N-benzyloxycarbonylpiperidine (230 mg) as colourless prisms, mp 83°-85° C. NMR (d6DMSO) δ0.9(3H,t), 0.9-1.1(2H,m); 1.3-1.5(2H,m); 1.5-1.8(5H,m); 2.7-2.9(4H,m); 2.95(2H,m); 4.0(2H,d); 5.1(2H,s); 7.0(1H,t); 7.3(5H,m). m/e 369(M+H)+ ; 391(M+Na)+ ; calculated for C18H28 N2SO4 : C, 58.7; H, 7.7; N, 7.6; found: C, 58.5; H, 7.8; N, 7.6%.